v3.26.1
Consolidated Statements of Stockholders' Deficit - USD ($)
$ in Thousands
Common stock
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total
Balance (in shares) at Dec. 31, 2024 77,704,188        
Balance at the beginning of the period at Dec. 31, 2024 $ 77 $ 2,574,611 $ (25,886) $ (3,646,873) $ (1,098,071)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 467,285        
Exercise of options   16,885     16,885
Restricted stock vesting and issuance, net (in shares) 1,134,189        
Restricted stock vesting and issuance, net $ 1       1
Issuance of common stock related to stock purchase agreement (in shares) 72,483        
Issuance of common stock related to stock purchase agreement   2,827     2,827
Share-based compensation expense   36,603     36,603
Receivable from investor   254     254
Net income (loss)       801,713 801,713
Comprehensive income (loss)     33,242   33,242
Balance (in shares) at Jun. 30, 2025 79,378,145        
Balance at the end of the period at Jun. 30, 2025 $ 78 2,631,180 7,356 (2,845,160) (206,546)
Balance (in shares) at Mar. 31, 2025 79,225,276        
Balance at the beginning of the period at Mar. 31, 2025 $ 78 2,608,422 (13,949) (2,780,311) (185,760)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 36,196        
Exercise of options   1,134     1,134
Restricted stock vesting and issuance, net (in shares) 44,190        
Issuance of common stock related to stock purchase agreement (in shares) 72,483        
Issuance of common stock related to stock purchase agreement   2,827     2,827
Share-based compensation expense   18,543     18,543
Receivable from investor   254     254
Net income (loss)       (64,849) (64,849)
Comprehensive income (loss)     21,305   21,305
Balance (in shares) at Jun. 30, 2025 79,378,145        
Balance at the end of the period at Jun. 30, 2025 $ 78 2,631,180 7,356 (2,845,160) (206,546)
Balance (in shares) at Dec. 31, 2025 81,474,366        
Balance at the beginning of the period at Dec. 31, 2025 $ 80 2,748,335 10,501 (2,964,229) (205,313)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 506,463        
Exercise of options $ 1 19,636     19,637
Restricted stock vesting and issuance, net (in shares) 1,294,464        
Restricted stock vesting and issuance, net $ 1       1
Repurchase of 2026 Convertible Notes   (102,734)     (102,734)
Conversion of 2026 Convertible Notes (in shares) 3,506        
Conversion of 2026 Convertible Notes   (2,899)     (2,899)
Issuance of common stock related to stock purchase agreement (in shares) 48,487        
Issuance of common stock related to stock purchase agreement   3,163     3,163
Share-based compensation expense   46,712     46,712
Receivable from investor   (133)     (133)
Net income (loss)       80,687 80,687
Comprehensive income (loss)     (4,484)   (4,484)
Balance (in shares) at Jun. 30, 2026 83,327,286        
Balance at the end of the period at Jun. 30, 2026 $ 82 2,712,080 6,017 (2,883,542) (165,363)
Balance (in shares) at Mar. 31, 2026 82,882,024        
Balance at the beginning of the period at Mar. 31, 2026 $ 81 2,778,026 8,466 (2,967,038) (180,465)
Increase (Decrease) in Stockholders' Equity          
Exercise of options (in shares) 344,594        
Exercise of options $ 1 13,233     13,234
Restricted stock vesting and issuance, net (in shares) 48,675        
Repurchase of 2026 Convertible Notes   (102,734)     (102,734)
Conversion of 2026 Convertible Notes (in shares) 3,506        
Conversion of 2026 Convertible Notes   (2,899)     (2,899)
Issuance of common stock related to stock purchase agreement (in shares) 48,487        
Issuance of common stock related to stock purchase agreement   3,163     3,163
Share-based compensation expense   23,291     23,291
Net income (loss)       83,496 83,496
Comprehensive income (loss)     (2,449)   (2,449)
Balance (in shares) at Jun. 30, 2026 83,327,286        
Balance at the end of the period at Jun. 30, 2026 $ 82 $ 2,712,080 $ 6,017 $ (2,883,542) $ (165,363)